These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29966902)

  • 1. Validated ion pair chromatographic method for simultaneous determination and in vitro dissolution studies of indacaterol and glycopyrronium from inhaled capsule dosage form.
    Salem YA; Hammouda MEA; Saleh NM; Abu El-Enin MA; El-Ashry SM
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Nov; 204():464-474. PubMed ID: 29966902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrophotometric and spectrofluorimetric determination of indacaterol maleate in pure form and pharmaceutical preparations: application to content uniformity.
    El-Ashry SM; El-Wasseef DR; El-Sherbiny DT; Salem YA
    Luminescence; 2015 Sep; 30(6):891-7. PubMed ID: 25620654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid simultaneous determination of indacaterol maleate and glycopyrronium bromide in inhaler capsules using a validated stability-indicating monolithic LC method.
    Zayed S; Belal F
    Chem Cent J; 2017 May; 11(1):36. PubMed ID: 29086816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous spectrophotometric determination of indacaterol and glycopyrronium in a newly approved pharmaceutical formulation using different signal processing techniques of ratio spectra.
    Abdel Ghany MF; Hussein LA; Magdy N; Yamani HZ
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Mar; 157():251-257. PubMed ID: 26779820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of IND/GLY (indacaterol/glycopyrronium) in COPD patients.
    Demin I; Bartels C; Graham G; Bieth B; Gautier A; Tillmann HC; Sechaud R
    Int J Clin Pharmacol Ther; 2016 Jun; 54(6):405-15. PubMed ID: 27049057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plackett-Burman and face-centered composite designs for development and optimization of chromatographic method for the simultaneous determination of glycopyrronium, indacaterol and mometasone in their fixed dose combination inhaler - Green profile assessment.
    Youssef YM; Mahrouse MA; Mostafa EA
    J Pharm Biomed Anal; 2023 Sep; 234():115553. PubMed ID: 37399700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects.
    Inoue S; Vaidya S; Tillmann HC; Sakita Y; Machineni S; Heudi O; Furihata K
    BMC Pulm Med; 2021 Jan; 21(1):18. PubMed ID: 33413291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple analytical methods for determination of formoterol and glycopyrronium simultaneously in their novel combined metered dose inhaler.
    Salem YA; Hammouda MEA; Abu El-Enin MA; El-Ashry SM
    BMC Chem; 2019 Dec; 13(1):75. PubMed ID: 31384822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Determination of Formoterol Fumarate and Budesonide Epimers in Metered Dose Inhaler Using Ion-Pair Chromatography.
    Salem YA; Shaldam MA; El-Sherbiny DT; El-Wasseef DR; El-Ashry SM
    J Chromatogr Sci; 2017 Nov; 55(10):1013-1020. PubMed ID: 28977479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated capillary electrophoretic method for the determination of indacaterol and its application to a pharmaceutical preparation.
    Güray T; Tunçel M; Uysal UD
    J Food Drug Anal; 2018 Apr; 26(2):842-848. PubMed ID: 29567256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once-daily inhalation as a combination in healthy subjects.
    Vaidya S; Jauernig J; Ethell B; Abdallah N; Machineni S; Drollmann A; Heudi O; Last S; Hahn M; Radhakrishnan R; Ignatenko S; Tillmann HC
    Pulm Pharmacol Ther; 2020 Oct; 64():101964. PubMed ID: 33035700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
    Ammari WG; Al-Qadhi Z; Khalil M; Tayyem R; Qammaz S; Oriquat G; Basheti IA; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):202-10. PubMed ID: 25229261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
    Kerwin E; Ferguson GT; Sanjar S; Goodin T; Yadao A; Fogel R; Maitra S; Sen B; Ayers T; Banerji D
    Lung; 2017 Dec; 195(6):739-747. PubMed ID: 28993871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of the LABA/LAMA dual bronchodilator indacaterol/glycopyrronium in a Swedish healthcare setting.
    Price D; Keininger D; Costa-Scharplatz M; Mezzi K; Dimova M; Asukai Y; Ställberg B
    Respir Med; 2014 Dec; 108(12):1786-93. PubMed ID: 25307414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study.
    Salomon J; Stolz D; Domenighetti G; Frey JG; Turk AJ; Azzola A; Sigrist T; Fitting JW; Schmidt U; Geiser T; Wild C; Kostikas K; Clemens A; Brutsche M
    Respir Res; 2017 Jan; 18(1):13. PubMed ID: 28077140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
    Papi A; Vestbo J; Fabbri L; Corradi M; Prunier H; Cohuet G; Guasconi A; Montagna I; Vezzoli S; Petruzzelli S; Scuri M; Roche N; Singh D
    Lancet; 2018 Mar; 391(10125):1076-1084. PubMed ID: 29429593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPTLC Method for Determination of R, R-Glycopyrronium Bromide and its Related Impurities.
    Soliman SM; El-Houssini OM
    J Chromatogr Sci; 2019 Oct; 57(9):799-805. PubMed ID: 31504300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD.
    Prakash A; Babu KS; Morjaria JB
    Int J Chron Obstruct Pulmon Dis; 2015; 10():111-23. PubMed ID: 25609944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Indacaterol/Glycopyrronium (IND/GLY) Versus Salmeterol/Fluticasone in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: The Chinese Cohort from the LANTERN Study.
    Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Patalano F; Banerji D
    COPD; 2016 Dec; 13(6):686-692. PubMed ID: 27715335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program.
    Tsiligianni I; Mezzi K; Fucile S; Kostikas K; Shen S; Banerji D; Fogel R
    COPD; 2017 Aug; 14(4):375-381. PubMed ID: 28594587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.